Mycobacteria Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Groups at high risk of TB

A
  • People with HIV infection
  • People who were infected in the last 2 years
  • Babies and young children
  • People who inject illegal drugs or abuse alcohol
  • People sick with other diseases that weaken the immune system
  • Medications such as corticosteroids, tumour necrosis factors alpha inhibiors, calcinerin inhibitors (which includes cyclosporine and tacrolimus) and xytocix chemotherapy.
  • Elderly people
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

BCG vaccine

A
  • Live attenuated vaccine
  • Derived from strain of* M. bovis*
  • High protective efficacy >70% against meningitis and miliary TB
  • Variable efficiacy against TB in adults
  • Adverse events:
    • Local s/c abscess and ulcers
    • Suppurative lymphadenitis
    • Rarely disseminated disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

*Mycobacteria *microbiology

A
  • Non-motile, nonspore-forming weakly gram positive rods; often appear slightly bent or beaded.
  • Obligate aerobes; simple growth requirements
  • Cell wall: 20 to 60 percent lipids.
  • Generation time of 12 to 48 hours.
  • Acid-fastness: form stable mycolate complexes with arylmethane dysed
  • Particles 1-5um in diameter
  • Aerobic
  • Non-spore forming
  • Nonmotile bacillus
  • High cell wall content of high molecular weight lipids.
  • Complete 4.4 MB circular genome sequence of the H37Rv strain
  • Very large proportion MTB genes encode enzymes involved in lipogenesis and lipoysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acid fast bacilli (AFBs)

A

Retain basic dyes when treated with acidic solutions (most other ogrniams swill decolourise). Hence, they are ‘acid-fast’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Immunology and pathogenesis

A
  • Spread by airborne droplets. Particles can remain airborne for minutes-hours.
  • Inhaled and lodge in the alveoli.
  • MTB taken up by alveolar macrophages.
  • Activated T lymphocytes and macrophages form granulomas that limit further replication.
  • Replicated slowly (15-20 hours) but continuously.
  • Spread by lymphatic system to hilar lymph nodes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TST

A

Uses cell mediated immunity

  • Alveolar macrophages infected interacts with T lymphocytes
  • Infected macrophage releases IL 12 and 18
  • Stimulate T lymphocytes to release interferon gamma
  • This stimulates phagocytosis of MTB in macrophage
  • Interferon gamma stimulates macrophages to release tumour necrosis factor alpha
  • T lymphocyte response is antigen specific

Intradermal administration of tuberculin

Delayed type hypersensitivity response to PPD (purified protein derivative)

  • PPD = crude mixture of antigens
  • Tuberculin positivity occurs 3-8 weeks after infection

Treatment of latent TB diagnosed on basis of TST reuslts = reduces risk of active disease by 60%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TST cut-off points

A

A TST of >5mm of induration is interpreted as a positive result in the following groups:

  • HIV infected persons
  • Recent contacts of TB case
  • Persos with fibrotic changes on CXR consistent with old, healed TB
  • Patients with organ transplants and other immunosuppressed patients

TST cutoff is determined by diameter of induration

  • 5mm = HIV
  • 10mm = if from country where infection common
  • 5mm = low risk and low prevalence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IGRAs

A

Newer IF gamma assays use a cocktail of MTB - specific region of difference 1 (RD1) antigens

  • Early secretory antigenic target 6 (ESAT6)
  • Culture filtrate protein 10 (CFP10)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment of latent TB

A

In those suitable for chemoprophylaxis treat adults with 6-9 months of 300mg isoniazid and 25mg pyridoxine.

In theonly study comparing the efficacy of different durations:

  • 6 months of treatment was 65 percent effective; and
  • 12 months of treatment was 75 percent effective (not not statistically different from 6 months) in preventing TB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnosis of active TB

A

May present with

  • Fever
  • Cough >3 weeks
  • Chest pain
  • Weight loss
  • Fatigue
  • Coughing up blood - haemoptysis
  • Decreased appetite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Primary TB signs and symptoms

A

Usually asymptomatic.

If symptomatic

  • Often fever alone
  • Changes on CXR - midlung
  • Hilar lymphadenopathy
  • RML atelectasis
  • Calficiations
  • Pleural effusion
  • Erythema nodosum
  • Conjunctivitis

Children; AIDS = progressive pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Reactivation pulmonary TB

A

Symptoms

  • Anorexia
  • Fatigue
  • Weight loss
  • Chills
  • Afternoon fever
  • Night sweats
  • Productive cough
  • WHO: test for TB if unexplained 2 weeks productive cough
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Reactivation TB Laboratory findings

A

Monos 10%, Increased Ca2+, decreases Na+ (addisons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Reactivation TB CXR

A

Adolescents and adults

  • Subapical posterior upperlobe > apex > lower lobe
    • Cavity up to 50%
  • Without adenopathy/calcification
  • Often nondescript lower lobe pneumonia
    • Elderly/paients with comorbidities
    • Children
    • HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the gold standard of diagnosis for TB?

A

**Culture. **There are three types of media

  • Solid media: 3-8 weeks
  • _Liquid broth: _1-3 weeks
  • Bacter MGIT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of TB

A

The most effective way of stopping transmission

  • Isolate
  • Start treatment with anti-TB medicine

Active pulmonary TB

4 drugs for the first two months

  • Isoniazid
  • Rifampicin
  • Pyrazinamide
  • Ethambutol

2 drugs for additional months

  • Isoniazid
  • Rifampicin

Never forget to add pyridoxine to all persons treated with isoniazid to prevent peripheral neuropathy

17
Q

TB medication

A

Isoniazid is the most effective bactericidal drug.

Rifampicin and pyrazinamide are the most important sterilising drugs.

  • Thought to act by killing different populations of semi-formant organisms (persisters)

Isoniazid and rifampicin are the most effective drugs at preventing the emergence of resistance to other drugs.

Pyrazinamide has good activity against intracellular organisms and is most active in the first 2 months of treatment;

  • it enables the total duration of treatment to be shortened to 6 months (for fully drug-sensitive infections).

Ethambutol is a bacteriostatic drug that is given to prevent the emergence of resistance.

18
Q

MDR-TB definitin

A

Resistance to at least

  • Isoniazid
  • Rifampicin
19
Q

Second line medications

A
  • Relatively less effective (limited sterilising capacity)
  • Poorly tolerated (significant potential for toxicity)
  • Expensive

Treatment may need to be administered for up to 2 years in MDR-TB

20
Q

Persons at increased risk fo MDR

A
  • People already receiving TB treatment
  • Those who have inadequate treatment for >2 weeks.
  • Contacts of known drug resistance patients
  • People born or living in areas wiht high prevalence of drug resistance TB
21
Q

XDR-TB

A

MDR TB plus resistance to:

  • Fluroquinolones
  • Plus at least one of the 3 injectable second line drugs (capreomycin, kanamycin or amikacin)
22
Q

What does successful management of TB require?

A
  • Judicious use of drugs
  • Supervised standardised treatment
  • Focused clinical, radiologic and bacteriologic follow up
  • Surgery when appropriate
  • Contract tracing
23
Q

Most common adverse drug reactions

A
  • Hepatirus
  • Gi disturbances
  • Rash
  • Weakness/fatigue
  • Joint pain
24
Q

What increases risk of ADR?

A
  • Female sex
  • Increased age
  • Increased baseline AST
  • Drug resistance
25
Q

Treatment outcomes

A

Cure: complete treatment and smear/culture negative

Completed: taken total number of doses

Relapse: after cure or completion develops positive smear/culture/active disease

Failure: positive smears or cultures after 4-5 months of treatment

Drug studies show >95% cure. Globally 80% cure and 4% death

26
Q

DOTs

A

Directly obserbed therapy.

  • Ensures compliance
  • Essential to prevent emergence of drug resistance

Average treatment success among all national DOTS programs is 82%. The DOTs strategy can double cure rates and has shown to be cost effective.

27
Q

Relationship between HIV and TB

A

10% risk/year of developing TB. TB is the leading killer among people living with HIV,

28
Q

HIV and TB clinical manifestations

A

Early HIV (more typical)

Late HIV

  • Adenopathy
  • Lower/middle lobe
  • Rare cavitation
  • More smear negative
  • More extrapulmonary
29
Q

Treatment of TB in HIV

A
30
Q

Extrapulmonary TB

A

Lymphatics

  • cervical
  • cold
  • PPD usually +ve

_Pleural _

  • Dx difficult (Pleural Bx histology > Bx culture fluid culture > fluid smear)
  • Unilateral, fever, nonproductive cough, pleuritic chest pain
  • Often lymphocytic exudate

CNS

  • Meningitis > tuberculoma > spinal
  • Subacute, progressive meningitis
  • 50% CXR abnormal
  • 1/3 have miliary disease
  • Multiple LPs for smear and culture improves diagnosis from 37% to 87%
    • 80% low CSF glucose
    • Usually lymphocytosis
  • PCR = 98% specific 56% sensitive

GI

  • Ileocaucal mural thickening

Pericardial

  • Difficult to diagnose in resource limited settings
  • Empiric treatment with steroid cover

Bone-joint TB

  • Potts disease (lower thoracic > lumbar region)
  • Intervertebral narrowing > anterior adj bone
  • 90% do well with medication
31
Q

Miliary TB

A

Described any progressive disseminated haematogenous TB.

32
Q
A